Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Cortés-Funes, Hernán
139  Ergebnisse:
Personensuche X
?
1

Topical heparin as an effective and safe treatment for pati..:

Rodríguez-Garzotto, Analia ; Iglesias-Docampo, Lara ; Díaz-García, C. Vanesa...
Therapeutic Advances in Medical Oncology.  14 (2022)  - p. 175883592210869 , 2022
Link: https://doi.org/10.1177/..
 
?
2

Mechanistic added value of a trans-Sulfonamide-Platinum-Com..:

Agudo-López, Alba ; Prieto-García, Elena ; Alemán, José...
Molecular Cancer.  16 (2017)  1 - p. , 2017
Link: https://doi.org/10.1186/..
 
?
3

Final 10-year results of the Breast International Group 2–9..:

Sonnenblick, Amir ; Francis, Prudence A. ; Azim Jr., Hatem A....
European Journal of Cancer.  51 (2015)  12 - p. 1481-1489 , 2015
Link: https://doi.org/10.1016/..
 
?
4

Risk factors associated with Clostridium difficile infectio..:

Rodríguez Garzotto, Analia ; Mérida García, Antonio ; Muñoz Unceta, Nerea...
Supportive Care in Cancer.  23 (2014)  6 - p. 1569-1577 , 2014
Link: https://doi.org/10.1007/..
 
?
5

Relevance of insulin-like growth factor 1 receptor gene exp..:

Agulló-Ortuño, M. Teresa ; Díaz-García, C. Vanesa ; Agudo-López, Alba...
Journal of Cancer Research and Clinical Oncology.  141 (2014)  1 - p. 43-53 , 2014
Link: https://doi.org/10.1007/..
 
?
6

The therapeutic role of fulvestrant in the management of pa..:

Ciruelos, Eva ; Pascual, Tomás ; Arroyo Vozmediano, María Luisa...
The Breast.  23 (2014)  3 - p. 201-208 , 2014
Link: https://doi.org/10.1016/..
 
?
7

A prognostic factor index for overall survival in patients ..:

Llombart-Cussac, Antonio ; Pivot, Xavier ; Biganzoli, Laura...
The Breast.  23 (2014)  5 - p. 656-662 , 2014
Link: https://doi.org/10.1016/..
 
?
8

Prognostic value of dual-specificity phosphatase 6 expressi..:

Díaz-García, C. Vanesa ; Agudo-López, Alba ; Pérez, Carlos...
Tumor Biology.  36 (2014)  2 - p. 1199-1206 , 2014
Link: https://doi.org/10.1007/..
 
?
9

DICER1, DROSHA and miRNAs in patients with non-small cell l..:

Díaz-García, C. Vanesa ; Agudo-López, Alba ; Pérez, Carlos...
Carcinogenesis.  34 (2013)  5 - p. 1031-1038 , 2013
Link: https://doi.org/10.1093/..
 
?
10

Behaviour of breast cancer molecular subtypes through tumou..:

Castaneda, Carlos A. ; Andrés, Eva ; Barcena, Carmen...
Clinical and Translational Oncology.  14 (2012)  6 - p. 481-485 , 2012
Link: https://doi.org/10.1007/..
 
?
11

Biological markers of cisplatin resistance in advanced test..:

García-Velasco, Adelaida ; Durán, Ignacio ; García, Elena...
Clinical and Translational Oncology.  14 (2012)  6 - p. 452-457 , 2012
Link: https://doi.org/10.1007/..
 
?
12

Safety of bevacizumab in metastatic breast cancer patients ..:

Cortés, Javier ; Caralt, Mireia ; Delaloge, Suzette...
European Journal of Cancer.  48 (2012)  4 - p. 475-481 , 2012
Link: https://doi.org/10.1016/..
 
?
13

A randomized phase II study to compare oxaliplatin plus 5-f..:

Gravalos, Cristina ; Salut, Antonieta ; García-Girón, Carlos...
Clinical and Translational Oncology.  14 (2012)  8 - p. 606-612 , 2012
Link: https://doi.org/10.1007/..
 
?
14

Phase I and pharmacokinetic study of trabectedin 3-hour inf..:

Pardo, Beatriz ; Salazar, Ramón ; Ciruelos, Eva...
Medical Oncology.  29 (2011)  3 - p. 2240-2250 , 2011
Link: https://doi.org/10.1007/..
 
?
15

The Role of RANK-Ligand Inhibition in Cancer: The Story of ..:

Castellano, Daniel ; Sepulveda, Juan Manuel ; García-Escobar, Ignacio...
The Oncologist.  16 (2011)  2 - p. 136-145 , 2011
Link: https://doi.org/10.1634/..
 
1-15